9 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
	99	Synthesis and structure-activity relationships of potent retinoid X receptor ligands	TBA
15006411	126	Design, synthesis and structure-activity relationship of novel RXR-selective modulators.	Ligand Pharmaceuticals
12482435	75	Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid.	Ligand Pharmaceuticals
10543887	12	Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.	University of Oklahoma Health Sciences Center
10479291	12	Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.	University of Oklahoma Health Sciences Center
8784454	76	Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.	Allergan
8071941	240	Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.	Ligand Pharmaceuticals
7636877	96	Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.	Ligand Pharmaceuticals
7608895	61	Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activity.	University of Alabama At Birmingham